CD123‐Targeted Therapy to Achieve Negative Measurable Residual Disease in Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm Prior to Transplantation

Fuente: Wiley Open Access
Guardado en:
Detalles Bibliográficos
Autores principales: Flavia Gava, Luiz Fernando Bazzo Catto, Marilia Bazzo Catto, Ana Luiza Morais, Maristella Bergamo Francisco dos Reis, Thiago Eleuterio Gonçalves, Luiz Guilherme Darrigo Jr, Carlos Alberto Scrideli, Elvis Terci Valera
Formato: Artículo Open Access
Publicado: Wiley 2025
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1867015139706798081
author Flavia Gava
Luiz Fernando Bazzo Catto
Marilia Bazzo Catto
Ana Luiza Morais
Maristella Bergamo Francisco dos Reis
Thiago Eleuterio Gonçalves
Luiz Guilherme Darrigo Jr
Carlos Alberto Scrideli
Elvis Terci Valera
author_facet Flavia Gava
Luiz Fernando Bazzo Catto
Marilia Bazzo Catto
Ana Luiza Morais
Maristella Bergamo Francisco dos Reis
Thiago Eleuterio Gonçalves
Luiz Guilherme Darrigo Jr
Carlos Alberto Scrideli
Elvis Terci Valera
Flavia Gava
Luiz Fernando Bazzo Catto
Marilia Bazzo Catto
Ana Luiza Morais
Maristella Bergamo Francisco dos Reis
Thiago Eleuterio Gonçalves
Luiz Guilherme Darrigo Jr
Carlos Alberto Scrideli
Elvis Terci Valera
collection Wiley Open Access
contents CD123‐Targeted Therapy to Achieve Negative Measurable Residual Disease in Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm Prior to Transplantation Flavia Gava Luiz Fernando Bazzo Catto Marilia Bazzo Catto Ana Luiza Morais Maristella Bergamo Francisco dos Reis Thiago Eleuterio Gonçalves Luiz Guilherme Darrigo Jr Carlos Alberto Scrideli Elvis Terci Valera Pediatric Blood & Cancer 10.1002/pbc.32034 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/pbc.32034
format Artículo Open Access
id wiley_oa_10_1002_pbc_32034
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle CD123‐Targeted Therapy to Achieve Negative Measurable Residual Disease in Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm Prior to Transplantation
Flavia Gava
Luiz Fernando Bazzo Catto
Marilia Bazzo Catto
Ana Luiza Morais
Maristella Bergamo Francisco dos Reis
Thiago Eleuterio Gonçalves
Luiz Guilherme Darrigo Jr
Carlos Alberto Scrideli
Elvis Terci Valera
Pediatric Blood & Cancer
CD123‐Targeted Therapy to Achieve Negative Measurable Residual Disease in Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm Prior to Transplantation Flavia Gava Luiz Fernando Bazzo Catto Marilia Bazzo Catto Ana Luiza Morais Maristella Bergamo Francisco dos Reis Thiago Eleuterio Gonçalves Luiz Guilherme Darrigo Jr Carlos Alberto Scrideli Elvis Terci Valera Pediatric Blood & Cancer 10.1002/pbc.32034 http://onlinelibrary.wiley.com/termsAndConditions#vor
title CD123‐Targeted Therapy to Achieve Negative Measurable Residual Disease in Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm Prior to Transplantation
topic Pediatric Blood & Cancer
url https://onlinelibrary.wiley.com/doi/10.1002/pbc.32034